← Back to Search

Device

Magnetically Controlled Capsule Endoscopy for Gastroparesis

Q: What is the enrolment figure for this clinical trial?

<p>Affirmative. Clinicaltrials.gov attests that this trial is currently enlisting contributors; it was first posted on the 1st of December 2021 and last updated on the 9th of January 2023, with a recruitment goal of 17 people from one facility.</p>

Q: Are there any opportunities to participate with this experiment?

<p>According to the information hosted on clinicaltrials.gov, this medical study is actively seeking out participants and has been since it was first posted in December 2021. The details of the trial were last updated on January 9th 2023.</p>

University of California Los Angeles, Los Angeles, CA

Targeting 2 different conditionsMagnetically Controlled Capsule EndoscopyN/AWaitlist AvailableLed by Lin Chang, MDResearch Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

G-POEM: The G-POEM procedure must have been performed at least 4 weeks prior to screening, GCSI score is < 3 which correlates to mild or less symptom severity

Must meet one of the following categories: Gastroparesis, Functional Dyspepsia, G-POEM, Controls

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upthrough study completion, an average of 1 year

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will assess whether a magnetically controlled capsule endoscopy is a useful tool in diagnosing gastroparesis and functional dyspepsia.

Eligible Conditions

Gastroparesis
Indigestion

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You must have one of the following conditions: Gastroparesis, Functional Dyspepsia, or have undergone G-POEM procedure. Or, you can be a control subject.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dyspepsia Severity Scale symptom ratings at baseline and during the study at timepoints with discomfort if present.

Frequency and direction of contractions

Largest diameter of the pylorus

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Group I: GastroparesisExperimental Treatment1 Intervention

Patients with a diagnosis of gastroparesis meeting the inclusion criteria

Group II: G-POEMExperimental Treatment1 Intervention

Patients who received a G-POEM procedure meeting the inclusion criteria

Group III: Functional DyspepsiaExperimental Treatment1 Intervention

Patients with a diagnosis of functional dyspepsia meeting the inclusion criteria

Group IV: ControlExperimental Treatment1 Intervention

No diagnosis of gastroparesis, functional dyspepsia, or prior G-POEM

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,493 Previous Clinical Trials

10,284,597 Total Patients Enrolled

Lin Chang, MDPrincipal InvestigatorUniversity of California, Los Angeles

4 Previous Clinical Trials

153 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrolment figure for this clinical trial?

"Affirmative. Clinicaltrials.gov attests that this trial is currently enlisting contributors; it was first posted on the 1st of December 2021 and last updated on the 9th of January 2023, with a recruitment goal of 17 people from one facility."

Answered by AI

Are there any opportunities to participate with this experiment?

"According to the information hosted on clinicaltrials.gov, this medical study is actively seeking out participants and has been since it was first posted in December 2021. The details of the trial were last updated on January 9th 2023."

Answered by AI

Recent research and studies

American Journal of GastroenterologyJournal

Clinical Guideline: Management of Gastroparesis

Camilleri, Michael, Henry P Parkman, Mehnaz A Shafi, Thomas L Abell, and Lauren Gerson. 2013. “Clinical Guideline: Management of Gastroparesis”. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health). doi:10.1038/ajg.2012.373.

Alimentary Pharmacology & TherapeuticsJournal

Development and Validation of a Patient-assessed Gastroparesis Symptom Severity Measure: The Gastroparesis Cardinal Symptom Index

Revicki, D. A., A. M. Rentz, D. Dubois, P. Kahrilas, V. Stanghellini, N. J. Talley, and J. Tack. 2003. “Development and Validation of a Patient-assessed Gastroparesis Symptom Severity Measure: The Gastroparesis Cardinal Symptom Index”. Alimentary Pharmacology & Therapeutics. Wiley. doi:10.1046/j.1365-2036.2003.01612.x.

clinicaltrials.govStudy

Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

Lin Chang, MD 2021. "Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05004012.

All > Diabetic Gastroparesis > Dyspepsia